Matrix delivery transdermal 17beta-estradiol for the prevention of bone loss in postmenopausal women. The International Study Group

Autor: Cooper, C, Stakkestad, JA, Radowicki, S, Hardy, P, Pilate, C, Dain, MP, Delmas, PD

A total of 277 early postmenopausal women were enrolled in this placebo-controlled 2-year study to examine the efficacy of a matrix transdermal 17beta-estradiol system, at three different dosages (25, 50 and 75 mg/day) combined with sequential oral d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c9ffa995e21b6d8af58d01bbdda63bcf
https://doi.org/10.1007/s001980050159

Matrix delivery transdermal 17 beta-estradiol for the prevention of bone loss in postmenopausal women

Autor: Cooper, C, Stakkestad, JA, Radowicki, S, Hardy, P, Pilate, C, Dain, MP, Delmas, PD, Grp, IS

Publikováno v: OSTEOPOROSIS INTERNATIONAL. 9(4)

A total of 277 early postmenopausal women were enrolled in this placebo-controlled 2-year study to examine the efficacy of a matrix transdermal 17β-estradiol system, at three different dosages (25, 50 and 75 μg/day) combined with sequential oral dy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ab317914dd2d1fc9ad8da88f5dbfdb
http://ora.ox.ac.uk/objects/uuid:9c970a65-e113-4f7d-a2c4-77e5129050e1

Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.

Autor: Lankisch MR; University of Witten/Herdecke, Düsseldorf, Germany. Electronic address: lankisch@kardioschlosspark.de., Del Prato S; University of Pisa, Pisa, Italy., Dain MP; Sanofi, Paris, France., Mullins P; University of Auckland, Auckland, New Zealand., Owens DR; Swansea University, Swansea, UK.

Publikováno v: Primary care diabetes [Prim Care Diabetes] 2016 Feb; Vol. 10 (1), pp. 51-9. Date of Electronic Publication: 2015 Jul 04.

Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study.

Autor: Arnolds S, Dellweg S, Clair J, Dain MP, Nauck MA, Rave K, Kapitza C, Arnolds, Sabine, Dellweg, Sibylle, Clair, Janina, Dain, Marie-Paule, Nauck, Michael A, Rave, Klaus, Kapitza, Christoph

Publikováno v: Diabetes Care; Jul2010, Vol. 33 Issue 7, p1509-1515, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.